Cancer Care Milestone: Aurobindo’s Eugia Pharma Preps for US Entry with Dasatinib Approval in Hand

Unknown Apr 02, 2026 600 Views

Aurobindo Pharma has declared a major regulatory victory, with its wholly-owned unit Eugia Pharma Specialities gaining final approval from the US Food and Drug Administration (USFDA) for Dasatinib Tablets. The drug is likely to be launched in the US market in the first quarter of FY26, the second...